Characterization of HER2 Expression in Primary Gastroesophageal Adenocarcinomas

被引:0
|
作者
Jeung, J. A. [1 ]
Patel, R. [1 ]
Vila, L. [1 ]
Wakefield, D. [1 ]
Liu, C. [1 ]
机构
[1] Univ Florida, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
646
引用
收藏
页码:153A / 154A
页数:2
相关论文
共 50 条
  • [21] HER2 Expression in Dysplastic Lesions of the Gastroesophageal Junction and Stomach
    Grin, Andrea
    Streutker, Catherine
    MODERN PATHOLOGY, 2015, 28 : 162A - 162A
  • [22] Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results
    Brunetti, Barbara
    de Biase, Dario
    Millanta, Francesca
    Muscatello, Luisa Vera
    Di Oto, Enrico
    Marchetti, Roberta
    Laddaga, Ester Lidia
    De Leo, Antonio
    Tallini, Giovanni
    Bacci, Barbara
    ANIMALS, 2024, 14 (18):
  • [23] HER2 Gene Amplification and Protein Expression in Pancreatic Ductal Adenocarcinomas
    Aumayr, Klaus
    Soleiman, Afschin
    Sahora, Klaus
    Schindl, Martin
    Werba, Gregor
    Schoppmann, Sebastian F.
    Birner, Peter
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (02) : 146 - 152
  • [24] HER2 expression in primary colorectal cancer
    Ben Lazreg, K.
    Majdoub, W.
    Mestiri, S.
    Bdioui, A.
    Hmissa, S.
    Missaoui, N.
    VIRCHOWS ARCHIV, 2024, 485 : S471 - S471
  • [25] HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies
    Robertson, Scott A.
    Cimino-Mathews, Ashley
    Cornish, Toby C.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (01) : 35 - 39
  • [26] Intratumoral Heterogeneity of Her2 Expression Patterns in Patients with gastroesophageal Adenocarcinoma
    Puhr, H. C.
    Jomrich, G.
    Paireder, M.
    Rieder, E.
    Radosavljevic, S.
    Birner, P.
    Macher-Beer, A.
    Preusser, M.
    Schoppmann, S. F.
    Ilhan-Mutlu, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 223 - 223
  • [27] Her2 status investigation by IHC and FISH in primary and metastatic gastric adenocarcinomas
    Vrettou, E.
    Bobos, M.
    Tzioufa, V.
    Petrakis, G.
    Raptou, G.
    Polyzou, A.
    VIRCHOWS ARCHIV, 2011, 459 : S186 - S186
  • [28] Comparison of HER2 gene amplification (AMP) in primary esophageal and gastroesophageal junction adenocarcinomas (EAC) and their metastatic regional lymph nodes (MLNs).
    Yoon, Harry H.
    Shi, Qian
    Sukov, William R.
    Sattler, Christopher A.
    Wiktor, Anne E.
    Diasio, Robert B.
    Wu, Tsung-Teh
    Jenkins, Robert B.
    Sinicrope, Frank A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] KRAS, BRAS mutations, and HER2 expression in patients operated for pancreatic adenocarcinomas
    Schultz, N. A.
    Roslind, A.
    Heeran, M.
    Christensen, I. J.
    Hogdall, E. V.
    Horn, T.
    Wojdemann, M.
    Balslev, E.
    Johansen, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] HER2 expression pattern in gastric adenocarcinomas in a Nigerian tertiary hospital by immunohistochemistry
    Mashor, M.
    Ezenkwa, U.
    Ogunbiyi, J.
    Ogun, G.
    Ajani, M.
    VIRCHOWS ARCHIV, 2020, 477 : S189 - S189